US Patent Issued to Genentech on July 28 for "KRAS specific antibodies and uses thereof" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,322, issued on July 28, was assigned to Genentech Inc. (South San Francisco, Calif.).

"KRAS specific antibodies and uses thereof" was invented by Melinda M Mulvihill (S. San Francisco, Calif.), John Gerard Quinn (S. San Francisco, Calif.), Micah Steffek (San Francisco), Weiru Wang (S. San Francisco, Calif.), John Bruning (S. San Francisco, Calif.), Christopher Williamson Davies (Oakland, Calif.), Marie Evangelista (San Francisco) and James Thomas Koerber (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are anti-KRas antibodies that bind to mutant KRas-GDP and alkylated mutant KRas-GDP and methods of using the same. A...